Not Yet RecruitingNot Applicable

We Will Compare Anxiety Levels Between English and Spanish-speaking Patients Before Surgery at a Children's Hospital. We Hypothesize That Spanish-speaking Patients Will Experience Greater Anxiety, so an Educational Intervention Will be Introduced One-week Before Surgery.

50 participantsStarted 2025-10

Plain-language summary

The goal of this trial is to first evaluate whether a difference exists in anxiety scores between Spanish-speaking children and English-speaking children in the pre-operative setting in our patient population as assessed by the validated myPAS-SF anxiety index. In the interventional phase, the investigators hypothesize that the use of a language-concordant, educational intervention by study participants at home during the week preceding surgery will decrease pre-operative anxiety in Spanish-speaking children, as assessed by the validated mYPAS-SF anxiety index.

Who can participate

Age range5 Years – 14 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hispanic/Latino Spanish-Speaking children ages 5-14 years * Undergoing surgery in the Doernbecher Operating Rooms Exclusion Criteria: * Subjects having cardiac surgery * Parent refusal of consent * Children that refuse assent * Children with psychiatric or atypical neurodevelopmental conditions such as autism or sensory processing disorders that put them at greater risk for pre-surgical anxiety, history of prior surgery, and children with global developmental delay as noted by ICD codes or diagnosis on their problem list Parent/Guardian Exclusion Criteria * Impaired decision-making adults * Incarcerated adults

What they're measuring

Anxiety score using the mYPAS-SF anxiety index

Timeframe: On average 1-2 weeks. From enrollment to day of surgery.

Trial details

NCT IDNCT06624410

SponsorOregon Health and Science University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01

Contact for this trial

Tomas A Lazo, MD

503-346-0264 lazo@ohsu.edu